Photophysical studies of hetero-bischelated complexes of rhodium(III) containing 2,2′-dipyridylamine

Four mixed-ligand complexes, cis-Rh[(bipy)(HDPA)Cl₂]Cl (1), cis-[Rh(phen)(HDPA)Cl₂]Cl (2), cis-[Rh(bipy)(DPA)Cl₂] (3), and cis-[Rh(phen)(DPA)Cl₂] (4) (where bipy = 2,2′-bipyridine, phen = 1,10-phenantroline, HDPA = 2,2′-dipyridylamine, and DPA = the deprotonated form of 2,2′-dipyridylamine) have been synthesized and characterized. In slightly acidic solution and at low temperature (77 K), both complexes 1 and 2 show a broad, symmetric and structureless red emission with microsecond lifetime identified as dd* phosphorescence. In slightly basic solution, the deprotonated complexes (3 and 4) exhibit a broad and asymmetric blue emission, showing no vibrational structure with a lifetime in the order of microseconds. Emission of complex 3 reveals a blue shift of 0.81 μm⁻¹ compared to the emission of complex 1 and that of complex 4 shows a blue shift of 0.77 μm⁻¹ with respect to complex 2. Electrochemical data have also been obtained for the four complexes in CH₃CN. There are two reduction peaks observed for both complexes 1 and 2. Each peak is followed by a one-electron reduction at the metal, with an elimination of chloride during each reduction step, which is in consistent with the dd* phosphorescence assignment for the two complexes. For complexes 3 and 4, only a one-electron reduction process occurs at the metal with an elimination of chloride. Based on the luminescence and electrochemical data, the emission of complexes 3 and 4 are assigned as πd* phosphorescence. Results from density functional theory (DFT) calculations provide theoretical evidence in support of this πd* assignments.     

Characterization and DNA-interaction studies of 1,1-dicyano-2,2-ethylene dithiolate Ni(II) mixed-ligand complexes with 2-amino-5-methyl thiazole, 2-amino-2-thiazoline and imidazole. Crystal structure of [Ni(i-MNT)(2a-5mt)2]

A series of mixed-ligand neutral nickel(II) complexes of the general formula [Ni(i-MNT)(2a-5mt)₂] (1), [Ni(i-MNT)(2a-2tzn)₂] (2) and [Ni(i-MNT)(Im)₂] (3), [where i-MNT^2? = the dianion of 1,1-dicyano-2,2-ethylenedithiolate, 2a-5mt = 2-amino-5-methyl thiazole, 2a-2tzn = 2-amino-2-thiazoline and Im = imidazole] were prepared and characterized with elemental analyses, spectroscopic (IR, UV–vis) methods, magnetic susceptibility, molar conductivity and cyclic voltammetry measurements. The magnetic data, the electronic spectra and the electrical conductivity measurements indicated mononuclear neutral complexes with square-planar geometry. The X-ray analysis of [Ni(i-MNT)(2a-5mt)₂] shows the nickel atom being fourfold coordinated with the two sulfur atoms of the dithiolate (i-MNT) ligand and the endocyclic nitrogen atoms from the two 2a-5mt ring giving rise to a slightly distorted square-planar arrangement. The cyclic voltammograms of the complexes have been recorded and the corresponding redox potentials have been estimated. The DNA-binding studies of the complexes has been evaluated by examining their ability to bind to calf-thymus DNA (CT DNA) with UV spectroscopy and cyclic voltammetry. Both studies have shown that the complexes can bind to CT-DNA by the intercalative and the electrostatic binding mode. Competitive binding studies with ethidium bromide (EB) with fluorescence spectroscopy have also shown that the complexes exhibit the ability to displace the DNA-bound EB indicating that they can bind to DNA in strong competition with EB.     

Synthesis,crystal structures,DNA binding and cytotoxicity of two novel platinum(II) complexes containing 2-(hydroxymethyl)pyridine and pyridine-2-carboxylate ligands

Two new platinum(II) complexes, trans-[Pt(2-mpy)₂]·4H₂O (1) and [PtCl(2-pyc)(2-hmpy)]·H₂O (2), where 2-hmpy = 2-(hydroxymethyl)pyridine, 2-mpy = deprotonated 2-hmpy and 2-pyc = pyridine-2-carboxylate, have been synthesized and characterized by elemental analysis, IR, NMR, and X-ray crystallography. The DNA binding affinities of these complexes for Fish Sperm DNA (FS-DNA) were investigated using fluorescence, viscosity, thermal denaturation and gel electrophoresis measurements. Fluorescence analysis indicates that complex 1 binds to DNA by a single intercalative mechanism, while complex 2 exhibits two types of interactions such as intercalation and covalent binding. Gel electrophoresis assay demonstrates ability of the complexes to cleavage the supercoiled pBR322 plasmid DNA. The in vitro cytotoxicities of both complexes were preliminarily evaluated and the cytotoxicity of complex 1 against the human lung cancer cells (H1299) is similar to oxaliplatin, but higher than transplatin and carboplatin.     

Structure and catalytic activity of rhodium(I) carbene complexes in polymerization of phenylacetylene

Rh(I) carbene complexes of [RhX(bmim)(η⁴-1,5-cod)] type (bmim = 1-butyl-3-methyl imidazolium cation, X = Cl 2, Br 3, I 4), obtained in the reaction of [Rh(OMe)(η⁴-1,5-cod)]₂ (1) with [bmim]X ionic liquids, catalyzed polymerization of phenylacetylene (PA) to cis-polyphenylacetylene (PPA) in CH₂Cl₂ and in ionic liquids. The yield of PPA increased and molecular weight (M_w) decreased after addition of phosphorus ligands PPh₃ or P(OPh)₃. Complex 4 reacted with P(OPh)₃ giving cis-[RhI(bmim)(P(OPh)₃)₂] (5) complex which catalyzed oligomerization but not polymerization of PA.     

Synthesis,EPR, electrochemistry and EXAFS studies of ruthenium(III) complexes with a symmetrical tetradentate N2O2 Schiff base

A series of new hexa-coordinated ruthenium(III) complexes of the type [RuX(Nap-o-phd)(EPh₃)] (where, H₂-Nap-o-phd = N,N′-bis(2-hydroxy-1-naphthaldehyde) o-phenylene diamine; X = Cl or Br; E = P or As) have been prepared by reacting [RuX₃(EPh₃)₃] and [RuBr₃(PPh₃)₂(MeOH)] (where X = Cl or Br; E = P or As) with tetradentate Schiff base ligand (H₂-Nap-o-phd) in 1:1 molar ratio. The complexes have been characterized by elemental analyses, infra red, electronic, electron paramagnetic resonance spectroscopy and cyclic voltammetry. The coordination geometry and structure of the complexes have been investigated by extended X-ray absorption fine structure (EXAFS) spectroscopy and an octahedral structure has been proposed.     

Two new N-heterocyclic carbene silver(I) complexes with the π–π stacking interactions

The precursors bis[N-(alkyl)benzimidazoliumylmethyl]durene halide (1a: alkyl = C₂H₅, halide = Br^?; 1b: alkyl = n-C₄H₉, halide = Cl^?; durene = 1,2,4,5-tetramethylbenzene) and their two new NHC silver(I) complexes [Durene(CH₂BimyEtAgBr)₂] (2a) and [Durene(CH₂BimyⁿBuAgCl)₂] (2b) (Bimy = benzimidazol-2-ylidene) have been prepared and characterized. In the crystal structures of 2a and 2b the aromatic π–π stacking interactions are observed.     

Effect of ligand congeniality on energy transfer reaction between photo-excited tris(bipyridine)ruthenium(II) and chromate(III) complexes in aqueous solutions

Energy-transfer rate-constants from photo-excited [Ru(N–N)₃]²⁺ (N–N = 2,2′-bipyridine (bpy), 4,4′-dimethyl-2,2′-bipyridine (4dmb), 5,5′-dimethyl-2,2′-bipyridine (5dmb)) to [Cr(O–O)₃]³⁻ (O–O²⁻ = ox²⁻ ((COO⁻)₂), mal²⁻ (CH₂(COO⁻)₂)) and [Cr(CN)₆]³⁻ in encounter complexes were evaluated in aqueous solutions containing alkali metal ion. The rate constant depends on the molecular size of the ruthenium(II) complex: 1.8 × 10⁸ s⁻¹ for [Ru(bpy)₃]²⁺ (molecular radius, r = 5.8 Å), 1.4 × 10⁸ s⁻¹ for [Ru(5dmb)₃]²⁺ (r = 6.1 Å) and 0.96 × 10⁸ s⁻¹ for [Ru(4dmb)₃]²⁺ (r = 6.7 Å) in the system of [Ru(N–N)₃]²⁺–[Cr(ox)₃]³⁻ in aqueous solution. However, the rate constant is much more sensitive to the chromate(III) complex than to ruthenium(II) complex; 1.8 × 10⁸ s⁻¹ and 0.43 × 10⁸ s⁻¹ for [Cr(ox)₃]³⁻ (r = 4.0 Å) and [Cr(mal)₃]³⁻ (r = 4.2 Å) in the [Ru(bpy)₃]²⁺–[Cr(O–O)₃]³⁻ systems, respectively. We conclude that the congeniality between the donor’s and acceptor’s ligands in encounter complex plays an important role in energy transfer in aqueous solution.     

DNA binding and photocleavage properties and apoptosis-inducing activities of a ruthenium porphyrin complex [(Py-3′)TPP-Ru(phen)2Cl]Cl and its heterometallic derivatives

The interactions of a ruthenium porphyrin complex [(Py-3′)TPP-Ru(phen)₂Cl]Cl (phen = 1,10-phenanthroline, (Py-3′)TPP = 5-(3′-pyridyl-10,15,20-triphenylporphyrin) (1) and its heterometallic derivatives, [Ni(Py-3′)TPP-Ru(phen)₂Cl][PF₆] (2) and [Cu(Py-3′)TPP-Ru(phen)₂Cl][PF₆] (3), with calf thymus DNA have been investigated by spectroscopic and viscosity measurements in this study. The results showed that these synthetic complexes can bind to double strand helix DNA in groove binding mode, and the intrinsic binding constants of complexes 1, 2 and 3, as calculated according to the decay of the Soret absorption, are (1.35 ± 0.5) ×10⁵ M^?1 (s = 4.2), (1.29 ± 0.5) × 10⁵ M^?1 (s = 5.6) and (1.22 ± 0.5) × 10⁵ M^?1 (s = 6.2) (s is the binding-site size), respectively, which are consistent with those obtained from ethidium bromide-quenching experiments. Further investigations on the photocleavage properties of these complexes on plasmid pBR 322 DNA showed that complexes 1, 2 and 3 could cleave single chain DNA and convert DNA molecules from supercoiled form to the nicked form. As determined by MTT assay, the complexes were also identified as potent antiproliferative agents against A375 human melanoma cells, MCF-7 human breast adrenocarcinoma cells, Colo201 human colon adenocarcinoma cells and HepG2 human liver cancer cells. Complex 1 inhibits the growth of A375 cells through induction of apoptotic cell death and G0/G1 cell cycle arrest. Further investigation on intracellular mechanisms indicated that Complex 1 induced depletion of mitochondrial membrane potential (ΔΨ_m) in A375 cells through regulating the expression of pro-survival and pro-apoptotic Bcl-2 family members. Our results suggest that ruthenium porphyrin complexes could be candidates for further evaluation as chemopreventive and chemotherapeutic agents for human cancers.     

Syntheses,structures, and magnetic properties of heterobimetallic complexes based on tetracyanometallic building blocks

Two tetracyanometalate building blocks, [Fe(5,5′-dmbipy)(CN)₄]^? (2) and [Fe(4,4′-dmbipy)(CN)₄]^? (3) (5,5′-dmbipy = 5,5′-dimethyl-2,2′-bipyridine; 4,4′-dmbipy = 4,4′-dimethyl-2,2′-bipyridine), and two cyano-bridged heterobimetallic complexes, [Cu₂(bpca)₂(H₂O)₂Fe₂(5,5′-dmbipy)₂(CN)₈] · 2[Cu(bpca)Fe(5,5′-dmbipy)(CN)₄] · 4H₂O (4) and [Cu(bpca)Fe(4,4′-dmbipy)(CN)₄]_n (5) (bpca = bis(2-pyridylcarbonyl)amidate), have been synthesized and structurally characterized. Complex 4 contains two dinuclear and one tetranuclear heterobimetallic clusters in an asymmetric unit whereas the structure of complex 5 features a one-dimensional heterobimetallic zigzag chain. The Cu(II) ion is penta-coordinated in the form of a distorted square-based pyramid. Magnetic studies show ferromagnetic coupling between Cu(II) and Fe(III) ions with g = 2.28, J₁ = 2.64 cm^?1, J₂ = 5.40 cm^?1 and TIP = ?2.36 × 10^?3 for complex 4, and g = 2.17, J = 4.82 cm^?1 and zJ′ = 0.029 cm^?1 for complex 5.     

Synthesis and biological evaluation of 3,6-diamino-1H-pyrazolo[3,4-b]pyridine derivatives as protein kinase inhibitors

The synthesis and biological evaluation of a number of differently substituted 3,6-diamino-1H-pyrazolo[3,4-b]pyridine derivatives are reported. From the inhibition results on a selection of disease-relevant protein kinases [IC₅₀ (μM) DYRK1A = 11; CDK5 = 0.41; GSK-3 = 1.5] we have observed that 3,6-diamino-4-phenyl-1H-pyrazolo[3,4-b]pyridine-5-carbonitrile (4) constitutes a potential new and simple lead compound in the search of drugs for the treatment of Alzheimer’s disease.     

8-Substituted 1,3-dimethyltetrahydropyrazino[2,1-f]purinediones: Water-soluble adenosine receptor antagonists and monoamine oxidase B inhibitors

Multitarget approaches, i.e., addressing two or more targets simultaneously with a therapeutic agent, are hypothesized to offer additive therapeutic benefit for the treatment of neurodegenerative diseases. Validated targets for the treatment of Parkinson’s disease are, among others, the A_2A adenosine receptor (AR) and the enzyme monoamine oxidase B (MAO-B). Additional blockade of brain A₁ ARs may also be beneficial. We recently described 8-benzyl-substituted tetrahydropyrazino[2,1-f]purinediones as a new lead structure for the development of such multi-target drugs. We have now designed a new series of tetrahydropyrazino[2,1-f]purinediones to extensively explore their structure–activity-relationships. Several compounds blocked human and rat A₁ and A_2AARs at similar concentrations representing dual A₁/A_2A antagonists with high selectivity versus the other AR subtypes. Among the best dual A₁/A_2AAR antagonists were 8-(3-(4-chlorophenyl)propyl)-1,3-dimethyl-6,7,8,9-tetrahydropyrazino[2,1-f]purine-2,4(1H,3H)-dione (41, K_i human A₁: 65.5 nM, A_2A: 230 nM; K_i rat A₁: 352 nM, A_2A: 316 nM) and 1,3-dimethyl-8-((2-(thiophen-2-yl)thiazol-4-yl)methyl)-6,7,8,9-tetrahydropyrazino[2,1-f]purine-2,4(1H,3H)-dione (57, K_i human A₁: 642 nM, A_2A: 203 nM; K_i rat A₁: 166 nM, A_2A: 121 nM). Compound 57 was found to be well water-soluble (0.7 mg/mL) at a physiological pH value of 7.4. One of the new compounds showed triple-target inhibition: (R)-1,3-dimethyl-8-(2,1,3,4-tetrahydronaphthalen-1-yl)-6,7,8,9-tetrahydropyrazino[2,1-f]purine-2,4(1H,3H)-dione (49) was about equipotent at A₁ and A_2AARs and at MAO-B (K_i human A₁: 393 nM, human A_2A: 595 nM, IC₅₀ human MAO-B: 210 nM) thus allowing future in vivo explorations of the intended multi-target approach.     

A multifrequency high-field EPR (9–285 GHz) investigation of a series of dichloride mononuclear penta-coordinated Mn(II) complexes

The electronic structure of a series of 11 penta-coordinated dichloride mononuclear Mn(II) complexes [Mn(L)Cl₂] (L = Cl-terpy, Br-terpy, OH-terpy, phenyl-terpy, tolyl-terpy, mesityl-terpy, EtO-terpy, Me₂N-terpy, tBu₃-terpy, py-phen, and dpya) has been investigated by a multifrequency EPR study (9–285 GHz). The X-ray structures of [Mn(Br-terpy)Cl₂], [Mn(EtO-terpy)Cl₂], [Mn(Me₂N-terpy)Cl₂] and [Mn(tolyl-terpy)Cl₂] are described. The spin Hamiltonian parameters have been determined for all complexes and show that the steric and electronic effects of the N-tridentate ligand L do not induce appreciable variations on the zero field splitting parameters. The magnitude of D, close to 0.3 cm⁻¹, is governed by the chloride anion. High-field EPR spectroscopy allows the determination of electronic parameters of mononuclear Mn(II) complexes characterized by relatively large magnitudes of D and the unambiguous interpretation of the X-band spectra of these kinds of complexes.     

Synthesis,electrochemistry and spectroscopy of lanthanide(III) homodinuclear complexes bridged by polyazine ligands

Six new complexes [Eu(tta)₃]₂bpm, [Er(tta)₃]₂bpm, [Tb(tta)₃]₂bpm, [Er(tta)₃]₂dpp, Pr(tta)₃bpm and Nd(tta)₃bpm (tta = 4,4,4-trifluoro-1-(2-thienyl)-1,3-butanedione, bpm = 2,2′-bipyrimidine, dpp = 2,3-bis(2-pyridyl)pyrazine) were prepared and studied. The electronic absorption spectra of the complexes display tta π → π* transitions in the UV region. Cyclic voltammetry of the complexes show an irreversible reduction followed by a reversible reduction both associated with the tta ligand. Eu(III) reduction in the homodinuclear [Eu(tta)₃]₂bpm complex occurs as an irreversible reduction at less negative potentials than the tta-based reductions. Emission spectra of the Eu(III) and Tb(III) bimetallics are typical of this type of bonding motif with ligand centered (tta) absorptions resulting in 4f–4f transitions in the visible and near infrared region.     

Synthesis and biological study of 3-(phenylsulfonyl)thieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidines as potent and selective serotonin 5-HT6 receptor antagonists

A number of 3-(phenylsulfonyl)thieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidines were prepared and their 5-HT₆ receptor binding affinity and ability to inhibit the functional cellular responses to serotonin were evaluated. 3-[(3-Chlorophenyl)sulfonyl]-N-(tetrahydrofuran-2-ylmethyl)thieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidin-5-amine 2{5,26} appeared to be the most active in a functional assay (IC₅₀ = 29.0 nM) and 3-(phenylsulfonyl)-N-(2-thienylmethyl) thieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidin-5-amine 2{1,28} demonstrated the greatest affinity in a 5-HT₆ receptor radioligand binding assay (K_i = 1.7 nM). A screening of 5-HT_2A and 5-HT_2B receptor affinity revealed that 3-(phenylsulfonyl)thieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidines are highly selective 5-HT₆ receptor ligands.     

Origin of magnetization tunneling in single-molecule magnets as determined by single-crystal high-frequency EPR

We review an extensive body of single-crystal high-frequency electron paramagnetic resonance (HFEPR) data in order to determine the transverse spin Hamiltonian parameters that control the tunneling of the direction of magnetization in a variety of integer and half-integer-spin single-molecule magnets (SMMs). The SMMs studied are members of the following families: S = 9/2 [Mn₄O₃Cl]⁶⁺; S = 5 [Mn₃NiO₄]⁶⁺; S = 6 [Mn₃ZnO₄]⁶⁺; and S = 4 [Ni₄(OR)₄]⁴⁺. HFEPR spectra for the half-integer S = 9/2 Mn₄ complexes that have C₃ symmetry do not provide measurable evidence for transverse spin Hamiltonian terms. This finding is consistent with the relatively large coercive field seen in the magnetization hysteresis loops for these complexes. On the other hand, a low symmetry S = 9/2 complex exhibits a much faster rate of ground-state magnetization tunneling, in agreement with HFEPR spectra for a powder sample that gives a rhombic zero-field splitting (ZFS) parameter of E = 0.140 cm^?1. The S = 5 Mn₃Ni systems exhibit magnetization tunneling that is much faster than seen for the high-symmetry S = 9/2 Mn₄ complexes. This can be attributed to their integer-spin ground states. Like the C₃ symmetry Mn₄ SMMs, the HFEPR spectra for high-symmetry Mn₃Ni complexes do not provide measurable evidence for transverse ZFS terms. However, the spectra exhibit broad peaks, suggesting distributions in the local molecular environments brought about by disordered solvate molecules. This disorder likely explains the fast tunneling in the high-symmetry S = 5 Mn₃Ni systems, though one cannot rule out fourth- (and higher-) order interactions that cannot be detected by HFEPR due to the broad resonances. The one S = 6 Mn₃Zn complex shows an even faster rate of tunneling compared to the isostructural S = 5 Mn₃Ni complex. Finally, the S = 4 [Ni(hmp)(dmb)Cl]₄ complex provides unique insights into the origin of fourth- (and higher-) order interactions found for many SMMs on the basis of analysis using a giant spin Hamiltonian (GSH) approximation. We conclude that the fourth-order anisotropy found for the S = 4 ground state of [Ni(hmp)(dmb)Cl]₄ originates from the second-order ZFS interactions associated with the individual Ni^II ions, but only as a result of higher-order processes that occur via S-mixing between the ground state and higher-lying (S < 4) spin-multiplets. The S-mixing is relatively strong in this system because of comparable exchange and anisotropy energy scales. The relatively fast tunneling is a direct consequence of this S-mixing, as opposed to any intrinsic fourth-order (spin–orbit) anisotropy associated with Ni^II.     

Discovery of simplified N2-substituted pyrazolo[3,4-d]pyrimidine derivatives as novel adenosine receptor antagonists: Efficient synthetic approaches,biological evaluations and molecular docking studies

In the present study, a molecular simplification approach was employed to design novel bicyclic pyrazolo[3,4-d]pyrimidine (PP) derivatives from tricyclic pyrazolo[4,3-e]-1,2,4-triazolo-[1,5-c]pyrimidines (PTP) as promising human A₃ adenosine receptor (hA₃AR) antagonists. All the target compounds were synthesized using novel and efficient synthetic schemes and the structure–activity relationship studies of these PPs were explored through the synthesis of a series of PTP analogues with various substituents. Substituents with different lipophilicity and steric hindrance (e.g., alkyl and aryl–alkyl) functions were introduced at N² position of the pyrazole ring, while acyl groups with different electronic properties were introduced at C⁶ position of the bicyclic nucleus to probe both electronic and positional effects. Most of the synthesized derivatives of the PP series presented good affinity at the hA₃AR, as indicated by the low micromolar range of K_i values and among them, compound 63 with N² neopentyl substituents showed most potent hA₃AR affinity with K_i value of 0.9 μM and high selectivity (hA₁AR/hA₃AR = >111 & hA_2AAR/hA₃AR = >111) towards other adenosine receptor subtypes. Interestingly, small isopropyl groups at N² position displayed high affinity at another receptor subtype (hA_2AAR, e.g., compound 55, with K_i hA_2AAR = 0.8 μM), while they were less favorable at the hA₃AR. Molecular docking analysis was also performed to predict the possible binding mode of target compounds inside the hA₃AR and hA_2AAR. Overall, PP derivatives represent promising starting points for new AR antagonists.     

Diverse magnetic and electrical properties of molecular solids containing the thiazyl radical BDTA

We have examined the crystal structures and the electrical and magnetic properties of the molecular compounds of a thiazyl radical, 1,3,2-benzodithiazolyl (abbreviated as BDTA). BDTA was found to be a useful building block for molecular conductors and magnets because it can operate as a counter cation, a donor or a ligand, depending on its charge. (i) A charge-transfer complex, [BDTA][TCNQ], crystallizes into a uniform segregated stacking structure with a short contact between the donor and acceptor columns. In spite of the partial charge transfer between the two components, this complex exhibits semiconductive behaviour, probably due to a large electron correlation on BDTA. (ii) The crystal structure of [BDTA][Ni(mnt)₂] (mnt = maleonitriledithiolate) consists of alternating stacking columns of S = 0 [BDTA]⁺ and S = 1/2 [Ni(mnt)₂]^?, in which a ferromagnetic coupling operates between the [Ni(mnt)₂]^? anions through the [BDTA] ⁺ cation. (iii) [BDTA]₂[Cu(mnt)₂] consists of an alternating stack of a head-to-head [BDTA]⁺ dimer and a planar [Cu(mnt)₂]^2? dianion. Short intermolecular S?S contacts between the stacks give rise to an ideal 1D Heisenberg antiferromagnetic chain of [Cu(mnt)₂]^2? with a coupling constant of J/k_B = 16–17 K. (iv) The crystal structure of [BDTA]₂[Co(mnt)₂] is similar to that of [BDTA]₂[Cu(mnt)₂] at 253 K, but this salt undergoes a phase transition at 190 K, below which a partial electron transfer occurs from [Co(mnt)₂]^2? to one of the [BDTA]⁺ cations along with formation of a coordination bond. (v) [BDTA][Ni(dmit)₂]₂ (dmit = 1,3-dithiol-2-thione-4,5-dithiolate) exhibits room-temperature conductivity of 0.1 S cm^?1 and semiconductive behaviour over the range 80–200 K, which can be interpreted in terms of multi-conducting bands.     

Exploring the 2- and 5-positions of the pyrazolo[4,3-d]pyrimidin-7-amino scaffold to target human A1 and A2A adenosine receptors

A new series of 7-aminopyrazolo[4,3-d]pyrimidine derivatives (1–31) were synthesized to evaluate some structural modifications at the 2- and 5-positions aimed at shifting affinity towards the human (h) A_2A adenosine receptor (AR) or both hA_2A and hA₁ ARs. The most active compounds were those featured by a 2-furyl or 5-methylfuran-2-yl moiety at position 5, combined with a benzyl or a substituted-benzyl group at position 2. Several of these derivatives (22–31) displayed nanomolar affinity for the hA_2A AR (K_i = 3.62–57 nM) and slightly lower for the hA₁ ARs, thus showing different degrees (3–22 fold) of hA_2A versus hA₁ selectivity. In particular, the 2-(2-methoxybenzyl)-5-(5-methylfuran-2-yl) derivative 25 possessed the highest hA_2A and hA₁ AR affinities (K_i = 3.62 nM and 18 nM, respectively) and behaved as potent antagonist at both these receptors (cAMP assays). Its 2-(2-hydroxybenzyl) analog 26 also showed a high affinity for the hA_2A AR (K_i = 5.26 nM) and was 22-fold selective versus the hA₁ subtype. Molecular docking investigations performed at the hA_2A AR crystal structure and at a homology model of the hA₁ AR allowed us to represent the hypothetical binding mode of our derivatives and to rationalize the observed SARs.     

Crystal structure,magnetic and thermal properties of the one-dimensional complex [Nd(pzam)3(H2O)Mo(CN)8] · H2O

The new d–f cyanido-bridged 1D assembly [Nd(pzam)₃(H₂O)Mo(CN)₈] · H₂O was prepared by self-assembly of pyrazine-2-carboxamide (pzam), Nd(NO₃) · nH₂O and (Bu₃NH)₃[Mo(CN)₈] · 4H₂O in acetonitrile. X-ray crystallographic studies indicate that the complex comprises chains of alternating, cyanido-bridged [Nd(pzam)₃(H₂O)]³⁺ and Mo(CN)₈]^3? fragments. The magneto-structural properties have been studied by field-dependent magnetization and specific heat measurements at low temperatures (?0.3 K). Below ≈10 K the Nd(III) moment is well approximated by an effective spin S = 1/2, with anisotropic g-tensor. The exchange coupling between the Nd(III) and the Mo(V) spins S = 1/2 along the structural chains is found to be ferromagnetic, with J/k_B = 1.8 ± 0.2 K and approximately XY (planar) anisotropy. No evidence for 3D interchain magnetic ordering is found. A comparison with magneto-structural data of other cyanido-bridged complexes involving the Nd(III) ion is presented.     

Probes for narcotic receptor mediated phenomena. 40. N-Substituted cis-4a-ethyl-1,2,3,4,4a,9a-hexahydrobenzofuro[2,3-c]pyridin-8-ols

A series of N-substituted rac-cis-4a-ethyl-1,2,3,4,4a,9a-hexahydrobenzofuro[2,3-c]pyridin-8-ols have been prepared using a simple synthetic route previously designed for synthesis of related cis-2-methyl-4a-alkyl-1,2,3,4,4a,9a-hexahydrobenzofuro[2,3-c]pyridin-6-ols. The new phenolic compounds, where the aromatic hydroxy moiety is situated ortho to the oxygen atom in the oxide-bridged ring, do not interact as well as the pyridin-6-ols with opioid receptors. The N-para-fluorophenethyl derivative had the highest μ-opioid receptor affinity of the examined compounds (K_i = 0.35 μM).